Samsung announces $50M digital health fund, wearable technology plans

Laura Pedulli | | Health Exec | Precision Medicine

The Silicon-Valley-based division of Samsung unveiled plans for an open platform for developers, medical professionals and hardware makers to advance digital health, reported CNBC.

The company announced open software and hardware efforts as well as a $50 million fund designed to help startups looking to work together on Samsung’s Digital Health Initiative.

It also revealed the reference design for a wearable that could track heart and respiratory rates, blood pressure and other data.

Samsung’s Simband is designed so companies can add in their own sensors, algorithms and innovations in other areas. The sensors involved include the usual ones, but also some innovative ones, such as light and acoustic sensors to measure other things going on inside the body. In addition, Samsung is working on a cloud-based, open source software platform to bring together fragmented data from a variety of sources for more useful analysis, according to CNBC.

More details on Samsung’s digital health plans are outlined here.

 

Laura Pedulli

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
ACC urges RFK Jr. to make Medicare reform a priority, warns against mass layoffs

The American College of Cardiology has sent a letter to HHS Secretary Robert F. Kennedy Jr. that outlines some of the organization’s central priorities and concerns. 

Radiology Business
FDA announces recall of Medtronic interventional radiology devices after 17 injuries, 4 deaths

One product is being pulled from the market, and the other is receiving updated instructions for use.

AI in Healthcare
What federal regulators can learn from the states about AI oversight

If the Trump administration continues taking a laissez-faire stance toward AI—including AI used in healthcare—why not let the states go it alone on regulating the technology?